Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC

NCT04945928 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT04945928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04945928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 27, 2021
Completion date
June 5, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, locally advanced cancer, pulmonary neoplasm